"Whether cancer, Alzheimer's, or cardiovascular diseases -- for more than 160 years, Pfizer has made a significant contribution to the prevention and successful treatment of common and rare diseases.
As the worldwide leading pharmaceutical company, Pfizer employs more than 100,000 people in 80 countries and invests more than $7 billion per year in research and development of its pharmaceutical products. The headquarters of Pfizer's German subsidiary is in Berlin.
To support tobacco cessation efforts, Pfizer developed a prescription medicine which has been sold in North America since 2006. Different to conventional nicotine substitutes, the nicotine-free tablet works on receptors in patients' brains and unleashes positive feelings similar to nicotine usage. Physical smoking cessation becomes much easier compared to 'cold turkey' withdrawal..."